APPLICATION
ANDA090585
TYPE
ANDA
ORIGINAL APPROVAL
2011-08-30
LATEST ACTION
2011-08-30
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ORPHENADRINE CITRATEPrescription
ORPHENADRINE CITRATE 30MG/ML · INJECTABLE · INJECTION
Approval history
2011-08-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.